Hadeel Delman Najim, Mohammed Mahmood Mohammed, and Abbas Mahdi Rahmah, “Influence of Adding Empagliflozin to Conventional Anti-diabetic Therapy on Quality of Life Scale for Type 2 Diabetic Patients”, IJPS, vol. 33, no. 3, pp. 142–149, Sep. 2024, doi: 10.31351/vol33iss3pp142-149.